MARY CASBARRO: Open Payments
NPI 1346793981 · LONDON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 47 payments from 14 companies in 2025. Trend: 2023 $836 · 2024 $994 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $276 |
| Astellas Pharma US Inc | 4 | $99 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $98 |
| OptumHealth Care Solutions, LLC | 5 | $81 |
| Biogen, Inc. | 3 | $46 |
| MILLICENT US INC | 2 | $37 |
| Gynesonics, Inc. | 2 | $34 |
| PFIZER INC. | 2 | $29 |
| Organon LLC | 2 | $23 |
| CooperSurgical, Inc. | 1 | $22 |
Products named: QULIPTA, Veozah, VIVIFY HEALTH CARE TEAM PORTAL 001, Sonata Sonography-Guided Transcervical Fibroid Ablation System, ZURZUVAE, UBRELVY, FEMLYV, COMIRNATY.
Industry payments across OH — which companies pay providers there.
